News

MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR™ Sirolimus Drug Eluting Balloon
July 10, 2020
Protaryx Medical Announces $8.3M in Funding for First-in-Class Technology for Left Atrial Access in Transcatheter Cardiac Procedures
July 10, 2020
…
Ancora Heart Receives IDE Approval for CorCinch-HF Pivotal Study of the AccuCinch® Ventricular Restoration System
July 10, 2020
…
Elixir Medical Announces 12-Month Data for DynamX Coronary Bioadaptor System, Demonstrating No Target Vessel Revascularization, No Thrombosis and Positive Adaptive Remodeling of the Artery
July 10, 2020
PARIS – July 10, 2020 — 
World’s First FDA IDE Coronary Patient Treated With a DEB
July 9, 2020
…
Neovasc Announces Circulatory System Devices Panel Meeting Date for Neovasc Reducer Device
July 9, 2020
Ticagrelor (Brilinta) Granted FDA Priority Review for the Reduction of Subsequent Stroke in Patients Who Had an Acute Ischemic Stroke or Transient Ischemic Attack
July 9, 2020
BRILINTA in combination with aspirin could be the first FDA-approved dual antiplatelet therapy to reduce the rate of stroke in these high-risk patients  
ACIST Medical Systems Announces Launch of the Latest Advance in FFR Microcatheters
July 9, 2020
Burlington Medical Introduces Lightest, Most Effective Radiation Protection Material Yet
July 9, 2020
New Core Material, Up to 21% Lighter,
Changes in Blood Platelets Triggered by COVID-19 Could Trigger Heart Attacks, Strokes
July 6, 2020
July 6, 2020 — Changes in blood platelets triggered by COVID-19 could contribute to the onset of heart attacks, strokes, and other serious complications in some patients who have the disease, according to University of Utah Health scientists.